Cargando…

Relevance of benign prostatic hyperplasia and associated conditions for urologists, health care systems, and society

Detalles Bibliográficos
Autores principales:	Oelke, Matthias, Gravas, Stavros
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809305/ https://www.ncbi.nlm.nih.gov/pubmed/20076962 http://dx.doi.org/10.1007/s00345-010-0507-9

Ejemplares similares

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

What do we really know about benign prostatic hyperplasia and lower urinary tract symptoms in adult men?
por: Oelke, Matthias, et al.
Publicado: (2011)

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia
por: Dimitropoulos, Konstantinos, et al.
Publicado: (2015)

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
por: Sabnis, Ravindra Bhalchandra, et al.
Publicado: (2021)

Korean Urologist's View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Oh, Cheol Young, et al.
Publicado: (2010)

Chinese Urologists' Views of Practice Patterns in the Diagnosis and Treatment of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Wu, Nan, et al.
Publicado: (2012)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Current status of 5α-reductase inhibitors in the management of lower urinary tract symptoms and BPH
por: Gravas, Stavros, et al.
Publicado: (2009)

Comparative analysis of benign prostatic hyperplasia management by urologists and nonurologists: A Korean nationwide health insurance database study
por: Park, Juhyun, et al.
Publicado: (2015)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Practice Patterns in Diagnosis and Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia among General Practitioners: Lessons Learnt from a Greek Survey
por: Samarinas, Michael, et al.
Publicado: (2018)

The fish-hook configuration of the distal ureter indicates bladder outlet obstruction due to benign prostatic hyperplasia
por: Mamoulakis, Charalampos, et al.
Publicado: (2010)

Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction
por: Sountoulides, Petros, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

The Role of the Urologist in Men's Health
por: Park, Hyun Jun
Publicado: (2017)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

Pathology Update for Urologists
por: Iczkowski, Kenneth A., et al.
Publicado: (2011)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Model‐based meta‐analysis of individual International Prostate Symptom Score trajectories in patients with benign prostatic hyperplasia with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2020)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
por: Gacci, Mauro, et al.
Publicado: (2013)

Robotic Assisted Simple Prostatectomy versus Holmium Laser Enucleation of the Prostate for Patients with Huge Benign Prostatic Hyperplasia
por: Kim, Hye Soo, et al.
Publicado: (2023)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Recent advances in managing benign prostatic hyperplasia: The Rezūm System
por: Guelce, Dominique, et al.
Publicado: (2018)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Prostate MRI – an update for the referring urologist
por: Czarniecki, Marcin, et al.
Publicado: (2016)

Model‐based meta‐analysis of the time to first acute urinary retention or benign prostatic hyperplasia‐related surgery in patients with moderate or severe symptoms
por: D'Agate, Salvatore, et al.
Publicado: (2021)

Ureteral obstruction in pregnancy – The “Stone Mountain” for the Urologist
por: Bres-Niewada, Ewa
Publicado: (2017)

Lighting the candle at both ends: Burnout in urologists
por: Panda, Arabind
Publicado: (2021)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_uuu7i44kkp8opugudmo3qdn51k